GGrantIndex
← Leaderboards

Diane E Griffin

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗
$24,000,430
Attributed
$26,636,328
Total exposure
17
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2005–24
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$27,845,874 · 18

By mechanism

R01$18,103,145 · 8
T32$6,404,050 · 1
U19$1,209,546 · 1
R56$818,095 · 1
P01$726,800 · 1
R21$445,500 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Virus”

Research focus

VirusCellsInfectionVirus DiseasesVirus ReplicationSindbis VirusImmune ResponseInterferonsAntibodiesIn VitroNeuronsImmuneProteinsCytokinePredispositionViralAlphavirusResponseEncephalomyelitisNeuraxisSurfaceMediatingAbbreviationsGlycoproteins

Grant awards (78)

Immunological and Physiological Responses to Measles Vaccine$786,462
R01 · FY2024 · AI · contact PI
Measles virus infection of the respiratory tract$409,375
R01 · FY2023 · AI · contact PI
Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection$1,209,546
U19 · FY2022 · AI
Measles virus infection of the respiratory tract$409,375
R01 · FY2022 · AI · contact PI
Physiological and immunological responses to measles vaccine$661,557
R01 · FY2021 · AI · contact PI
Measles virus infection of the respiratory tract$409,375
R01 · FY2021 · AI · contact PI
Physiological and immunological responses to measles vaccine$661,557
R01 · FY2020 · AI · contact PI
Measles virus infection of the respiratory tract$409,375
R01 · FY2020 · AI · contact PI
Role of the nsP3 macrodomain in alphavirus virulence$818,095
R56 · FY2019 · AI · contact PI
Physiological and immunological responses to measles vaccine$661,557
R01 · FY2019 · AI · contact PI
Physiological and immunological responses to measles vaccine$676,557
R01 · FY2018 · AI · contact PI
Role of CD4 T cells in fatal alphavisus encephalomyelitis$354,375
R01 · FY2018 · NS · contact PI
Role of CD4 T cells in fatal alphavisus encephalomyelitis$354,375
R01 · FY2017 · NS · contact PI
Role of CD4 T cells in fatal alphavisus encephalomyelitis$354,375
R01 · FY2016 · NS · contact PI
Control of alphavirous replacation in the nervous system$354,375
R01 · FY2016 · NS · contact PI
Role of CD4 T cells in fatal alphavisus encephalomyelitis$81,500
R01 · FY2016 · NS · contact PI
Role of CD4 T cells in fatal alphavisus encephalomyelitis$354,375
R01 · FY2015 · NS · contact PI
Control of alphavirous replacation in the nervous system$354,375
R01 · FY2015 · NS · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$424,613
T32 · FY2014 · AI · contact PI
Role of CD4 T cells in fatal alphavisus encephalomyelitis$354,375
R01 · FY2014 · NS · contact PI
Control of alphavirous replacation in the nervous system$350,832
R01 · FY2014 · NS · contact PI
Vitamin A-Mediated Protection in Measles$243,000
R21 · FY2014 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$507,302
T32 · FY2013 · AI · contact PI
Control of alphavirous replacation in the nervous system$341,972
R01 · FY2013 · NS · contact PI
Vitamin A-Mediated Protection in Measles$202,500
R21 · FY2013 · AI · contact PI
2013 Infections of the Nervous System: Pathogenesis and Worldwide Impact GRC$5,000
R13 · FY2013 · NS · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$499,422
T32 · FY2012 · AI · contact PI
Control of alphavirous replacation in the nervous system$354,375
R01 · FY2012 · NS · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$450,573
T32 · FY2011 · AI · contact PI
Control of Alphavirus Replication in the Nervous System$351,575
R01 · FY2011 · NS · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$427,416
T32 · FY2010 · AI · contact PI
Control of Alphavirus Replication in the Nervous System$369,789
R01 · FY2010 · NS · contact PI
TRAINING:MOLECULAR & CELLULAR BASES OF INFECTIOUS DISEAS$561,179
T32 · FY2009 · AI · contact PI
Control of Alphavirus Replication in the Nervous System$417,718
R01 · FY2009 · NS · contact PI
Control of Alphavirus Replication in the Nervous System$358,750
R01 · FY2008 · NS · contact PI
ACUTE ALPHAVIRAL ENCEPHALITIS$358,502
R01 · FY2008 · NS · contact PI
TRAINING:MOLECULAR & CELLULAR BASES OF INFECTIOUS DISEAS$316,297
T32 · FY2008 · AI · contact PI
Infectious Diseases of the Nervous System: Pathogenesis and Worldwide Impact$47,000
R13 · FY2008 · NS · contact PI
Control of Alphavirus Replication in the Nervous System$43,933
R01 · FY2008 · NS · contact PI
TRAINING:MOLECULAR & CELLULAR BASES OF INFECTIOUS DISEAS$527,841
T32 · FY2007 · AI · contact PI
ACUTE ALPHAVIRUAL ENCEPHALITIS$358,502
R01 · FY2007 · NS · contact PI
Control of Alphavirus Replication in the Nervous System$358,203
R01 · FY2007 · NS · contact PI
Immune Responses During Measles Virus Infection$310,055
R01 · FY2007 · AI · contact PI
2007 Viruses & Cells Gordon Conference$19,800
R13 · FY2007 · AI · contact PI
TRAINING:MOLECULAR & CELLULAR BASES OF INFECTIOUS DISEAS$440,389
T32 · FY2006 · AI · contact PI
Immune Responses During Measles Virus Infection$369,221
R01 · FY2006 · AI · contact PI
ACUTE ALPHAVIRUAL ENCEPHALITIS$369,209
R01 · FY2006 · NS · contact PI
TRAINING:MOLECULAR &CELLULAR BASES OF INFECTIOUS DISEAS$526,299
T32 · FY2005 · AI
Immune Responses During Measles Virus Infection$426,545
R01 · FY2005 · AI
ACUTE ALPHAVIRUAL ENCEPHALITIS$378,094
R01 · FY2005 · NS
ACUTE ALPHAVIRUAL ENCEPHALITIS$378,094
R01 · FY2004 · NS
TRAINING IN MOLEC AND CELL BASES OF INFECTIOUS DISEASE$369,139
T32 · FY2004 · AI
Immune Responses During Measles Virus Infection$327,000
R01 · FY2004 · AI
CONTROL OF ALPHAVIRUS REPLICATION IN THE NERVOUS SYSTEM$317,463
R01 · FY2004 · NS
Immune Responses During Measles Virus Infection$48,478
R01 · FY2004 · AI
MEASLES VACCINE DEVELOPMENT$35,765
P51 · FY2004 · RR
ACUTE ALPHAVIRAL ENCEPHALITIS$403,865
R01 · FY2003 · NS
TRAINING IN MOLEC AND CELL BASES OF INFECTIOUS DISEASE$368,374
T32 · FY2003 · AI
CONTROL OF ALPHAVIRUS REPLICATION IN THE NERVOUS SYSTEM$322,095
R01 · FY2003 · NS
Immune Responses During Measles Virus Infection$163,500
R01 · FY2003 · AI
CONTROL OF ALPHAVIRUS REPLICATION IN THE NERVOUS SYSTEM$43,151
R01 · FY2003 · NS
MEASLES VACCINE DEVELOPMENT$31,173
P51 · FY2003 · RR
ACUTE ALPHAVIRAL ENCEPHALITIS$394,024
R01 · FY2002 · NS
TRAINING IN MOLEC AND CELL BASES OF INFECTIOUS DISEASE$343,642
T32 · FY2002 · AI
CONTROL OF ALPHAVIRUS REPLICATION IN THE NERVOUS SYSTEM$286,125
R01 · FY2002 · NS
ROLE OF IMMUNE RESPONSE IN HIV ASSOCIATED NEUROLOGIC DISEASE$220,513
P01 · FY2002 · NS
ACUTE ALPHAVIRAL ENCEPHALITIS$384,961
R01 · FY2001 · NS
MEASLES VACCINES--IMMUNE RESPONSES AND ATYPICAL MEASLES$365,063
R01 · FY2001 · AI
TRAINING IN MOLEC AND CELL BASES OF INFECTIOUS DISEASE$331,084
T32 · FY2001 · AI
CONTROL OF ALPHAVIRUS REPLICATION IN THE NERVOUS SYSTEM$286,125
R01 · FY2001 · NS
IMMUNE RESPONSE DURING MEASLES VIRUS INFECTION$247,486
R01 · FY2001 · AI
ROLE OF IMMUNE RESPONSE IN HIV ASSOCIATED NEUROLOGIC DISEASE$220,513
P01 · FY2001 · NS
ACUTE ALPHAVIRAL ENCEPHALITIS$376,342
R01 · FY2000 · NS
MEASLES VACCINES--IMMUNE RESPONSES AND ATYPICAL MEASLES$354,430
R01 · FY2000 · AI
TRAINING IN MOLEC AND CELL BASES OF INFECTIOUS DISEASE$310,480
T32 · FY2000 · AI
IMMUNE RESPONSE DURING MEASLES VIRUS INFECTION$240,353
R01 · FY2000 · AI
ROLE OF IMMUNE RESPONSE IN HIV ASSOCIATED NEUROLOGIC DISEASE$142,887
P01 · FY2000 · NS
ROLE OF IMMUNE RESPONSE IN HIV ASSOCIATED NEUROLOGIC DISEASE$142,887
P01 · FY2000 · NS